Leland Gershell

Stock Analyst at Oppenheimer

(4.54)
# 278
Out of 5,043 analysts
141
Total ratings
50.38%
Success rate
29.23%
Average return

Stocks Rated by Leland Gershell

Viridian Therapeutics
Oct 21, 2025
Maintains: Outperform
Price Target: $32$36
Current: $23.17
Upside: +55.37%
Crinetics Pharmaceuticals
Sep 30, 2025
Maintains: Outperform
Price Target: $73$87
Current: $42.06
Upside: +106.85%
Tectonic Therapeutic
Sep 3, 2025
Initiates: Outperform
Price Target: $80
Current: $17.88
Upside: +347.43%
Xeris Biopharma Holdings
Aug 8, 2025
Maintains: Outperform
Price Target: $7$8
Current: $9.23
Upside: -13.33%
Soleno Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $105$110
Current: $68.66
Upside: +60.21%
BridgeBio Pharma
Aug 6, 2025
Maintains: Outperform
Price Target: $60$61
Current: $64.50
Upside: -5.43%
Alnylam Pharmaceuticals
Aug 4, 2025
Upgrades: Outperform
Price Target: $490
Current: $475.98
Upside: +2.95%
Lexeo Therapeutics
Jul 31, 2025
Initiates: Outperform
Price Target: $20
Current: $10.08
Upside: +98.41%
Rhythm Pharmaceuticals
Jul 10, 2025
Maintains: Outperform
Price Target: $76$110
Current: $113.46
Upside: -3.05%
Capricor Therapeutics
Jun 23, 2025
Maintains: Outperform
Price Target: $43$22
Current: $6.18
Upside: +255.99%
Maintains: Outperform
Price Target: $215$224
Current: $204.49
Upside: +9.54%
Maintains: Outperform
Price Target: $10$31
Current: $20.18
Upside: +53.62%
Initiates: Outperform
Price Target: $10
Current: $2.08
Upside: +380.77%
Maintains: Outperform
Price Target: $704$708
Current: $836.39
Upside: -15.35%
Initiates: Outperform
Price Target: $10
Current: $1.73
Upside: +478.03%
Maintains: Outperform
Price Target: $12$20
Current: $10.54
Upside: +89.75%
Upgrades: Outperform
Price Target: $98
Current: $53.49
Upside: +83.21%
Maintains: Outperform
Price Target: $48$52
Current: $33.65
Upside: +54.53%
Reiterates: Outperform
Price Target: $50
Current: $3.67
Upside: +1,264.26%
Maintains: Outperform
Price Target: $47$53
Current: $21.98
Upside: +141.13%
Reiterates: Outperform
Price Target: $30
Current: $7.81
Upside: +284.12%
Reiterates: Outperform
Price Target: $12
Current: $3.00
Upside: +300.00%
Maintains: Outperform
Price Target: $30,000$5,000
Current: $4.20
Upside: +118,947.62%
Maintains: Outperform
Price Target: $30$25
Current: $5.09
Upside: +391.16%
Maintains: Outperform
Price Target: $14$20
Current: $3.11
Upside: +543.09%
Reiterates: Outperform
Price Target: $29
Current: $21.36
Upside: +35.77%
Upgrades: Outperform
Price Target: $35
Current: $18.38
Upside: +90.42%
Maintains: Outperform
Price Target: $10
Current: $0.74
Upside: +1,255.93%
Maintains: Outperform
Price Target: $23$20
Current: $0.93
Upside: +2,043.62%
Maintains: Outperform
Price Target: $16$13
Current: $1.83
Upside: +610.38%
Maintains: Outperform
Price Target: $150$120
Current: $3.81
Upside: +3,049.61%
Downgrades: Perform
Price Target: n/a
Current: $9.37
Upside: -
Initiates: Perform
Price Target: n/a
Current: $19.78
Upside: -
Initiates: Outperform
Price Target: $50
Current: $1.56
Upside: +3,105.13%
Upgrades: Perform
Price Target: n/a
Current: $18.95
Upside: -